LAUSR

This timely and important article by Bloom et al. [1] highlights findings that warrant special attention in an effort to address and reduce racial disparities in low-risk prostate cancer. At the population level, African-American (AA) men are 76% more likely to be diagnosed with prostate cancer and 2.2-times more likely to die from prostate cancer compared with other men in the USA. Emerging evidence suggests that racial disparities in patients diagnosed with advanced stage or higher-risk disease may be predominantly accounted for by social factors and healthcare access [1,2]. In contrast, there is growing evidence that raises the question of whether disparities in low-risk disease may be driven by underlying tumour and/or biopsy misclassification differences [2–4].